Springactive, Inc.

Medtech · Private

Quasi-Active Prosthetic Ankle System (QPAS) — a motorized prosthetic ankle that uses battery energy to dynamically tune ankle stiffness and equilibrium angle for adaptive gait across varied terrain

Grants
$1.5M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$3.8M
8 awards · Defense
#144 of 4531 in medtech
Patents
23
9 granted · 14 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Soldier Power Regeneration Kit (spark)$99,000
Federal contractDepartment of Defense · Soldier Power Regeneration Kit (spark) Phase II$342,000
Federal contractDepartment of Defense · Build, Demonstrate, And Supply A Bionic Foot Controller$47,000
Federal contractDepartment of Defense · Conventional Motor/gearbox System$621,600
Federal contractDepartment of Defense · Ffp-loe Contract# 12311001$1,734,587
Federal contractDepartment of Defense · Jtar 2.0 R&d$680,156
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Quasi-Active Prosthetic Ankle System: Dynamic Angle and Stiffness Optimizations for Multiple Gait Activities$150,000
Federal grantDepartment of Health and Human Services · Phase II · Powered Walk/Run Prosthetic Ankle$614,838
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Quasi-Active Prosthetic Ankle System: Dynamic Angle and Stiffness Optimizations for Multiple Gait Activities$749,986
Federal contractDepartment of Defense · Igf::ct::igf Dhp Phase I Proposal No. H16C-007-0068$150,000
Federal contractDepartment of Defense · Igf::ot::igf. Dha Phase I Proposal H17A-005-0031 Titled "wireless Imu Sensing For Activity Control Of Ankle Prosthesis."$150,000
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
141SUVICA INC$4.0M—
142IMMUNETICS, INC.$4.0M$1.5M
143SWITCHBOX INC$4.0M—
144Springactive, Inc.$3.8M—
145Mattek Corporation$3.8M—
146MDxHealth$3.7M—
147Invitae Corp$3.7M$203M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 9 granted of 23

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.